Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization

Cellular Microbiology

Volumn 14, Issue 1, 2012, Pages 95-106

  Mishra, Meenu ^a   Byrd, Matthew S ^b   Sergeant, Susan ^c,d   Azad, Abul K ^a   Parsek, Matthew R ^e   McPhail, Linda ^c   Schlesinger, Larry S ^a   Wozniak, Daniel J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C7; PS1 POLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME DEGRADATION; FEMALE; GENE OVEREXPRESSION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTERNALIZATION; LUNG; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; MACROPHAGE; MEDIATOR; MUTANT; NEUTROPHIL; NONHUMAN; OPSONIZATION; OXIDATIVE STRESS; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; SERUM; WILD TYPE;

ANIMALS; COMPLEMENT C3; COMPLEMENT C5; COMPLEMENT C7; CYSTIC FIBROSIS; HUMANS; LUNG; MICE; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REACTIVE OXYGEN SPECIES;

PSEUDOMONAS AERUGINOSA;

EID: 83655163672     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01704.x     Document Type: Article

References (55)

1. Abdul Ajees, A., Gunasekaran, K., Volanakis, J.E., Narayana, S.V., Kotwal, G.J., and Murthy, H.M. (2006) The structure of complement C3b provides insights into complement activation and regulation. Nature 444: 221-225.
2. Abeyrathne, P.D., Daniels, C., Poon, K.K., Matewish, M.J., and Lam, J.S. (2005) Functional characterization of WaaL, a ligase associated with linking O-antigen polysaccharide to the core of Pseudomonas aeruginosa lipopolysaccharide. J Bacteriol 187: 3002-3012.
3. Balagopal, A., MacFarlane, A.S., Mohapatra, N., Soni, S., Gunn, J.S., and Schlesinger, L.S. (2006) Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74: 5114-5125.
4. Barker, J.H., McCaffrey, R.L., Baman, N.K., Allen, L.A., Weiss, J.P., and Nauseef, W.M. (2009) The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils. Microbes Infect 11: 762-769.
5. Bloch, E.F., Schmetz, M.A., Foulds, J., Hammer, C.H., Frank, M.M., and Joiner, K.A. (1987) Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. J Immunol 138: 842-848.
6. Briheim, G., Stendahl, O., and Dahlgren, C. (1984) Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun 45: 1-5.
7. Buckles, E.L., Wang, X., Lane, M.C., Lockatell, C.V., Johnson, D.E., Rasko, D.A., etal. (2009) Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 199: 1689-1697.
8. Bylund, J., Burgess, L.A., Cescutti, P., Ernst, R.K., and Speert, D.P. (2006) Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J Biol Chem 281: 2526-2532.
9. Byrd, M.S., Sadovskaya, I., Vinogradov, E., Lu, H., Sprinkle, A.B., Richardson, S.H., etal. (2009) Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol Microbiol 73: 622-638.
10. Clay, C.D., Soni, S., Gunn, J.S., and Schlesinger, L.S. (2008) Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisellatularensis lipopolysaccharide O antigen. J Immunol 181: 5568-5578.
11. Crowther, J.E., Kutala, V.K., Kuppusamy, P., Ferguson, J.S., Beharka, A.A., Zweier, J.L., etal. (2004) Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 172: 6866-6874.
12. Engels, W., Endert, J., Kamps, M.A., and van Boven, C.P. (1985) Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa. Infect Immun 49: 182-189.
13. Feingold, D.S., Goldman, J.N., and Kuritz, H.M. (1968a) Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol 96: 2118-2126.
14. Feingold, D.S., Goldman, J.N., and Kuritz, H.M. (1968b) Locus of the lethal event in the serum bactericidal reaction. J Bacteriol 96: 2127-2131.
15. Ferrer, N.L., Gomez, A.B., Neyrolles, O., Gicquel, B., and Martin, C. (2010) Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages. PLoS ONE 5: e12978.
16. Friedman, L., and Kolter, R. (2004) Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J Bacteriol 186: 4457-4465.
17. Goebel, E.M., Wolfe, D.N., Elder, K., Stibitz, S., and Harvill, E.T. (2008) O antigen protects Bordetella parapertussis from complement. Infect Immun 76: 1774-1780.
18. Goldman, J.N., Ruddy, S., Austen, K.F., and Feingold, D.S. (1969) The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli. J Immunol 102: 1379-1387.
19. Gondwe, E.N., Molyneux, M.E., Goodall, M., Graham, S.M., Mastroeni, P., Drayson, M.T., and MacLennan, C.A. (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA 107: 3070-3075.
20. Govan, J.R., and Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
21. Gross, G.N., Rehm, S.R., and Pierce, A.K. (1978) The effect of complement depletion on lung clearance of bacteria. J Clin Invest 62: 373-378.
22. Hancock, R.E., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P., and Pier, G.B. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170-177.
23. Heale, J.P., Pollard, A.J., Stokes, R.W., Simpson, D., Tsang, A., Massing, B., and Speert, D.P. (2001) Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa. J Infect Dis 183: 1214-1220.
24. Iida, K., Whitlow, M.B., and Nussenzweig, V. (1989) Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J Exp Med 169: 881-891.
25. Inoue, K., and Yonemasu, K. (1968) Studies on the third component (C'3) of guinea pig complement. II. Decay and generation of SAC' la, 4, 2a, 3. Biken J 11: 181-191.
26. Jackson, K.D., Starkey, M., Kremer, S., Parsek, M.R., and Wozniak, D.J. (2004) Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol 186: 4466-4475.
27. Jesaitis, A.J., Franklin, M.J., Berglund, D., Sasaki, M., Lord, C.I., Bleazard, J.B., etal. (2003) Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 171: 4329-4339.
28. Joiner, K.A., Schmetz, M.A., Sanders, M.E., Murray, T.G., Hammer, C.H., Dourmashkin, R., and Frank, M.M. (1985) Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci USA 82: 4808-4812.
29. Kampen, A.H., Tollersrud, T., and Lund, A. (2005) Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro. Infect Immun 73: 1578-1583.
30. Kanegasaki, S. (1986) Studies on phagocyte response to bacteria: conditions for efficient interaction and mechanism of oxygen radical production. Tokai J Exp Clin Med 11 (Suppl.): 97-102.
31. Karakawa, W.W., Sutton, A., Schneerson, R., Karpas, A., and Vann, W.F. (1988) Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 56: 1090-1095.
32. Kolb, W.P., Haxby, J.A., Arroyave, C.M., and Muller-Eberhard, H.J. (1972) Molecular analysis of the membrane attack mechanism of complement. J Exp Med 135: 549-566.
33. Kondos, S.C., Hatfaludi, T., Voskoboinik, I., Trapani, J.A., Law, R.H., Whisstock, J.C., and Dunstone, M.A. (2010) The structure and function of mammalian membrane-attack complex/perforin-like proteins. Tissue Antigens 76: 341-351.
34. Learn, D.B., Brestel, E.P., and Seetharama, S. (1987) Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun 55: 1813-1818.
35. Leid, J.G., Willson, C.J., Shirtliff, M.E., Hassett, D.J., Parsek, M.R., and Jeffers, A.K. (2005) The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175: 7512-7518.
36. Longhi, C., Conte, M.P., Penta, M., Cossu, A., Antonini, G., Superti, F., and Seganti, L. (2004) Lactoferricin influences early events of Listeria monocytogenes infection in THP-1 human macrophages. J Med Microbiol 53: 87-91.
37. van Lookeren Campagne, M., Wiesmann, C., and Brown, E.J. (2007) Macrophage complement receptors and pathogen clearance. Cell Microbiol 9: 2095-2102.
38. Lorenzen, D.R., Gunther, D., Pandit, J., Rudel, T., Brandt, E., and Meyer, T.F. (2000) Neisseria gonorrhoeae porin modifies the oxidative burst of human professional phagocytes. Infect Immun 68: 6215-6222.
39. Lyczak, J.B., Cannon, C.L., and Pier, G.B. (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
40. Ma, L., Jackson, K.D., Landry, R.M., Parsek, M.R., and Wozniak, D.J. (2006) Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol 188: 8213-8221.
41. Ma, L., Conover, M., Lu, H., Parsek, M.R., Bayles, K., and Wozniak, D.J. (2009) Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5: e1000354.
42. Mai, G.T., Seow, W.K., Pier, G.B., McCormack, J.G., and Thong, Y.H. (1993) Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Infect Immun 61: 559-564.
43. Matsukawa, M., and Greenberg, E.P. (2004) Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol 186: 4449-4456.
44. Mohapatra, N.P., Soni, S., Rajaram, M.V., Dang, P.M., Reilly, T.J., El-Benna, J., etal. (2010) Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J Immunol 184: 5141-5150.
45. Mueller-Ortiz, S.L., Drouin, S.M., and Wetsel, R.A. (2004) The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun 72: 2899-2906.
46. Nauseef, W.M. (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219: 88-102.
47. Pangburn, M.K., and Muller-Eberhard, H.J. (1980) Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp Med 152: 1102-1114.
48. Pedersen, S.S., Kharazmi, A., Espersen, F., and Hoiby, N. (1990) Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun 58: 3363-3368.
49. Roos, D., van Bruggen, R., and Meischl, C. (2003) Oxidative killing of microbes by neutrophils. Microbes Infect 5: 1307-1315.
50. Saldias, M.S., Ortega, X., and Valvano, M.A. (2009) Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J Med Microbiol 58: 1542-1548.
51. Schreiber, R.D., Morrison, D.C., Podack, E.R., and Muller-Eberhard, H.J. (1979) Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med 149: 870-882.
52. Speert, D.P., Wright, S.D., Silverstein, S.C., and Mah, B. (1988) Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa. J Clin Invest 82: 872-879.
53. Thakker, M., Park, J.S., Carey, V., and Lee, J.C. (1998) Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun 66: 5183-5189.
54. Walker, T.S., Tomlin, K.L., Worthen, G.S., Poch, K.R., Lieber, J.G., Saavedra, M.T., etal. (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73: 3693-3701.
55. Wolfgang, M.C., Kulasekara, B.R., Liang, X., Boyd, D., Wu, K., Yang, Q., etal. (2003) Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100: 8484-8489.